BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35358005)

  • 1. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.
    Liu J; Lin F; Wang X; Li C; Qi Q
    Bioengineered; 2022 Apr; 13(4):7972-7983. PubMed ID: 35358005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA binding protein 5 (GATA5) induces Rho GTPase activating protein 9 (ARHGAP9) to inhibit the malignant process of lung adenocarcinoma cells.
    Ji W; Zhang L; Zhu H
    Bioengineered; 2022 Feb; 13(2):2878-2888. PubMed ID: 35040754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
    Qu G; Zhang Y; Duan H; Tang C; Yang G; Chen D; Xu Y
    Apoptosis; 2023 Jun; 28(5-6):783-795. PubMed ID: 36881291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway.
    Ye Z; Xia Y; Li L; Li B; Chen W; Han S; Zhou X; Chen L; Yu W; Ruan Y; Cheng F
    Transl Oncol; 2023 Jan; 27():101578. PubMed ID: 36375375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms.
    Qi Y; Mo K; Zhang T
    Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
    Wang ZY; Duan Y; Wang P
    J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.
    Qin L; Sun X; Zhou F; Liu C
    World J Surg Oncol; 2021 Jun; 19(1):184. PubMed ID: 34158077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
    Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
    Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
    Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC
    Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HP1α promotes the progression of prostate cancer.
    Zhang S; Li H; Shen C; Cao F; Kang S
    Mol Biol Rep; 2023 May; 50(5):4459-4468. PubMed ID: 37014569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 18. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑195‑5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
    Chen B; Bai G; Ma X; Tan L; Xu H
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.